Feedback PLC Director/PDMR Shareholding (4314V)
August 07 2020 - 1:00AM
UK Regulatory
TIDMFDBK
RNS Number : 4314V
Feedback PLC
07 August 2020
Feedback plc
Grant of Director Options
London, 07 August 2020: Feedback plc (AIM: FDBK, "Feedback" or
the "Company"), the specialist medical imaging technology company,
announces that it has granted options over 13,498,748 new Ordinary
Shares ("CEO Options"), representing 1.27 per cent. of the
Company's issued share capital, to Tom Oakley, CEO of Feedback.
The CEO Options are exercisable at a price of 1.2 pence at any
time up to the tenth anniversary of the date of grant. One-third of
the CEO Options vest immediately, one-third will vest one year from
date of grant and the balance will vest two years from the date of
the grant. The grant of the CEO Options and the issue price were
approved by shareholders at the General Meeting of the Company held
on 29 August 2019. Of the CEO Options, 12,356,667 were granted
pursuant to the EMI Option Scheme and the balance of 1,142,081
options were granted pursuant to the Non Tax-Advantaged Option
Scheme.
Tom Oakley now hold options over 22,820,829 Ordinary Shares,
equivalent to 2.14 % of the Company's voting rights. In total
60,330,829 Options are now outstanding, representing approximately
5.65 % of the Company's current issued share capital.
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Tom Oakley
------------------------------ -------------------------------------------
2 Reason for the notification
---------------------------------------------------------------------------
a) Position/status Chief Executive Officer
------------------------------ -------------------------------------------
b) Initial notification Initial Notification
/Amendment
------------------------------ -------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
---------------------------------------------------------------------------
a) Name Feedback plc
------------------------------ -------------------------------------------
b) LEI 213800UGOF2GT2U2RV90
------------------------------ -------------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
---------------------------------------------------------------------------
a) Description of the Options over Ordinary Shares of 0.25p
financial instrument, each in Feedback plc
type of instrument
Identification code Identification code (ISIN) for Feedback
plc ordinary shares: GB0003340550
------------------------------ -------------------------------------------
b) Nature of the transaction Grant of options
------------------------------ -------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
Exercise price of
1.2p per share 13,498,748
------------------------------ -------------------------- ---------------
d) Aggregated information
- Aggregated volume N/A
- Price
- Principal amount
------------------------------ -------------------------------------------
e) Dates of the transaction 6 August 2020
f) Place of transaction Outside of a trading venue
------------------------------ -------------------------------------------
-Ends-
Enquiries:
Feedback plc +44 (0)1954 718072
Tom Oakley, CEO IR@fbk.com
Lindsay Melvin, CFO
Allenby Capital Limited (Nominated Adviser)
David Worlidge / Asha Chotai +44 (0)20 3328 5656
Peterhouse Capital Limited (Joint Broker)
Lucy Williams / Duncan Vasey +44 (0)20 7469 0936
Stanford Capital Partners Limited (Joint
Broker)
Patrick Claridge / John Howes +44 20 3815 8880
Instinctif Partners +44 (0)20 7457 2020
Melanie Toyne-Sewell / Phillip Marriage +44 7890 022 814
feedbackplc@instinctif.com
Notes to editors
About Bleepa
Bleepa provides instant and remote access to clinical grade
medical images through a zero footprint application. The majority
of patient cases require medical imaging which can be seamlessly
shared to the entire clinical team through Bleepa. Cases can be
discussed through its secure instant messaging and image
annotation, allowing comments and treatment decisions to be
communicated instantly between team members. Bleepa can be accessed
from any internet connected device including phones, tablets,
laptops and desktops; clinicians can use their own devices and
therefore no additional hardware is required.
About Feedback plc - www.fbk.com
Feedback plc (AIM: FDBK) is a specialist medical imaging
technology company providing innovative software and systems,
through its fully-owned trading subsidiary, Feedback Medical
Limited. Its products advance the work of radiologists, clinicians
and medical researchers by improving workflows and giving unique
insights into diseases, particularly cancer.
Feedback has launched Bleepa (R) , a new secure, encrypted
medical communication app for clinicians accessible through
smartphones, tablets and desktops that facilitates rapid clinical
messaging and review of medical grade imaging for all members of a
clinical team, directly from a hospital Picture Archiving and
Communications System (PACS). For more information on Bleepa , see
www.bleepa.com .
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHUPURWRUPUGBQ
(END) Dow Jones Newswires
August 07, 2020 02:00 ET (06:00 GMT)
Feedback (LSE:FDBK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Feedback (LSE:FDBK)
Historical Stock Chart
From Apr 2023 to Apr 2024
